Bultos en el Seno

A randomized controlled trial found that gum arabic improved plaque index and gingival index in patients with plaque-induced gingivitis. Research in periodontal disease demonstrates GA's ability to disrupt bacterial quorum sensing and biofilm formation by key periodontal pathogens, making it a studied adjunct to conventional therapy.

Acemannan stimulates gingival fibroblast proliferation, KGF-1, VEGF, and type I collagen expression, supporting periodontal tissue regeneration. Clinical trials show it enhances dimensional bone stability in guided bone regeneration, and case reports document improved clinical parameters and radiographic bone fill over 5 years.

Thymol, the principal constituent of ajwain, is a clinically validated antiseptic agent used in commercial dental mouthwashes and approved for oral use. Ajwain oil has shown direct antibacterial activity against periodontal pathogens in vitro. A 2025 clinical trial demonstrated ajwain oil's superior analgesic properties vs. lidocaine in a pediatric dental setting.

Allspice oil's eugenol content confers antimicrobial and anti-inflammatory activity relevant to gum health. Eugenol-based products are established in dentistry for periodontal applications. In vitro studies confirm P. dioica essential oil inhibits oral pathogens including MRSA and Staphylococcus aureus.

Aloe vera gel has been studied as an adjunct to non-surgical periodontal therapy, demonstrating antibacterial activity against key periodontal pathogens including Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis. Subgingival injection of aloe vera gel has been shown to enhance periodontal health outcomes. A 2021 systematic review included aloe vera among antioxidant therapies significantly improving periodontal parameters in type 2 diabetic patients.

The German Commission E and EMA monograph approve topical arnica for inflammation of the oral and throat region, including gingivitis and aphthous ulcers. Helenalin has documented antibacterial activity against periodontal pathogens. A completed placebo-controlled RCT compared arnica to diclofenac sodium for analgesia following periodontal surgery (NCT03520595), and a separate RCT found topical arnica beneficial for pain 5 days after third molar surgery.

Small clinical studies and a PMC review show that barberry extract reduces dental plaque comparably to commercial toothpaste, and that berberine has anti-inflammatory properties relevant to periodontitis. Barberry fruit has been noted to promote dental hygiene by reducing plaque and gingivitis.

In vitro studies, including a 2023 PMC-published study, show that O. basilicum extracts exhibit significant antibacterial activity against anaerobic periodontal pathogens such as Porphyromonas gingivalis and Tannerella forsythia. Activity was lower than chlorhexidine but demonstrated a clear dose-response. These findings support potential use in periodontal care.

Propolis extracts have been evaluated in multiple RCTs for periodontal and gingival conditions. A 2021 multicenter RCT in 104 patients with gingivitis and periodontitis found propolis mouthwash significantly reduced modified gingival index at 4 and 8 weeks, and lowered crevicular IL-6. A comprehensive systematic review identified propolis and quercetin as the natural products with the highest antioxidant, anti-inflammatory, and antimicrobial activity in periodontal disease management.

Berberine has documented anti-inflammatory activity against key periodontal pathogens and mediators in experimental models. It suppresses TNF-α, IL-1β, IL-17, RANKL, and matrix metalloproteinases involved in periodontal tissue destruction. Gut microbiota modulation by berberine may also attenuate estrogen-deficiency-related periodontal bone loss.

Betel leaf demonstrates antibacterial activity against key periodontal pathogens including Streptococcus mutans, Porphyromonas gingivalis, and Actinomyces viscosus. A randomized clinical trial with betel-leaf toothpaste in gingivitis patients showed significant reduction in gingival bleeding and plaque scores. Traditional use for strengthening gums is widely documented.

Sodium bicarbonate-containing dentifrices have been evaluated in multiple RCTs and meta-analyses for plaque control and gingivitis reduction. A systematic review and meta-analysis of seven RCTs found that 67% sodium bicarbonate toothpaste significantly improved gingival index, bleeding index, and plaque index compared to controls. Proposed mechanisms include mechanical abrasion of biofilm, pH neutralization inhibiting acid-tolerant bacteria, and direct bactericidal effects on periodontal pathogens.

Bifidobacterium animalis subspecies lactis has been evaluated in RCTs for gingivitis and periodontal disease management. A Frontiers in Dental Medicine review of 36 periodontal RCTs listed Bifidobacterium animalis subsp. lactis among evaluated probiotic strains. An RCT by Kuru et al. (2017) specifically evaluated B. animalis probiotic influence on gingival health.

Black tea extract and its theaflavin derivatives have demonstrated antibacterial activity against key periodontal pathogens including Porphyromonas gingivalis in controlled laboratory and human oral epithelial cell studies. Theaflavins also modulate host inflammatory responses in gingival tissue. Clinical periodontal trials are limited but mechanistic evidence is strong.

Laboratory research has confirmed black walnut's antimicrobial activity against oral periodontal pathogens. A study specifically examined black walnut's antibacterial potential for various oral microbial diseases including periodontal disease. Traditional use as a tincture applied to gums is well-documented.

A 2022 randomized crossover study found that chewing gum containing 50 mg freeze-dried blackberry powder significantly reduced total salivary bacterial load and the relative abundance of six of nine targeted oral bacterial pathogens compared to xylitol-only gum. Traditional use of blackberry as a mouthwash for spongy gums and oral inflammation is also well-documented.

Multiple human RCTs have evaluated calendula mouthwash and toothpaste for plaque and gingivitis. A 240-patient RCT found that calendula tincture rinse significantly reduced plaque index, gingival index, and bleeding scores over six months. ESCOP cites controlled clinical evidence for gingivitis and periodontitis.

Cardamom extract has demonstrated in vitro antibacterial and anti-inflammatory activity relevant to periodontal disease. A 2019 study in an oral medicine journal provided evidence that cardamom fruit and seed extracts showed antibacterial and anti-inflammatory activity through NF-κB inhibition against periodontal pathogens. Antimicrobial activity against S. mutans and Candida species in oral biofilm studies has also been documented. Human clinical periodontal trials are limited.

BCP reduced gingival inflammation in an in vitro model of oral mucositis using human gingival fibroblasts and epithelial cells via CB2/NF-κB/PPARγ mechanisms. In a canine in vivo study, BCP reduced dental plaque formation more effectively than chlorhexidine.

EGCG possesses well-documented antibacterial and anti-inflammatory actions against periodontal pathogens including Porphyromonas gingivalis, Prevotella, and Fusobacterium. Clinical RCTs have demonstrated that EGCG used as an adjunct to scaling and root planing reduces gingival bleeding index and improves periodontal parameters.

A human split-mouth clinical trial of A. aspera gel as a local drug delivery agent in chronic periodontitis showed clinically relevant improvements in probing depth and clinical attachment level after 3 months. This is one of the few human clinical studies on this plant.

Chamomile (Matricaria chamomilla) mouthwash has been evaluated in clinical studies and shown to reduce bleeding index in patients with gingivitis and chronic periodontitis. It is widely included in herbal dental mouthwash products for anti-inflammatory, antiseptic, and gum-healing properties. A clinical study by Lucena et al. reported a decline in gingivitis bleeding index with chamomile remedy.

Cinnamon EO and extracts inhibit key periodontal pathogens including Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans, and Enterococcus faecalis in vitro. A PMC review specifically concluded cinnamon EO and extracts show significant antimicrobial activity against pathogens causing periodontal disease. Traditional use of cinnamon oil as an oral antiseptic for gum disorders is pharmacopoeially documented.

Multiple RCTs confirm that coconut oil pulling reduces plaque index, gingival index, and periodontal pathogenic bacteria. A 2025 triple-blind RCT found VCO pulling comparable to chlorhexidine in reducing bacterial load and inflammatory markers in chronic periodontitis patients, with favorable effects on oral microbiome composition.

Oil pulling with coconut oil—a practice using its fat fraction—has been tested in clinical trials and shown to reduce plaque, gingivitis scores, and Streptococcus mutans counts in saliva. A 2020 systematic review (PMC) concluded that oil pulling with coconut oil may have a beneficial effect on oral health, though evidence quality is mixed.

Several RCTs and a 2025 triple-blind RCT show coconut oil (via oil pulling) reduces periodontal pathogens, plaque index, bleeding on probing, and inflammatory cytokines in patients with periodontitis. Lauric acid inhibits pro-inflammatory cytokines including IL-6 and TNF-α in periodontal tissues. Evidence supports coconut oil as an adjunct to standard nonsurgical periodontal therapy.

Bioactive collagen peptides supplemented orally have been evaluated in a double-blind RCT in chronic periodontitis aftercare patients, with the collagen group showing significantly decreased bleeding on probing sites and lower periodontal inflamed surface area scores vs. placebo at 90 days. Collagen peptides are the primary structural protein of the periodontium and their supplementation supports connective tissue repair in treated periodontitis.

Multiple clinical studies and a 2025 systematic review with meta-analysis demonstrate that Commiphora myrrh mouthwash significantly reduces plaque accumulation and gingival inflammation. Commission E and ESCOP formally endorse myrrh for gingivitis and stomatitis.

CoQ10 has been evaluated in multiple RCTs as an adjunct to scaling and root planing for periodontitis. A 2025 systematic review and meta-analysis of 10 RCTs found that oral supplementation at 120 mg/day resulted in significantly greater mean reductions in probing pocket depth (0.41 mm) and clinical attachment level gain (0.52 mm) vs. controls. Locally delivered CoQ10 gel also reduces gum bleeding.

Cranberry polyphenols (particularly proanthocyanidins and phenolic acids) have demonstrated anti-biofilm and antibacterial activity against key periodontal pathogens including P. gingivalis, F. nucleatum, and A. actinomycetemcomitans in validated in vitro biofilm models. A 2021 systematic review found that omega-3 fatty acids combined with cranberry juice improved periodontal parameters in type 2 diabetic patients.

Curcumin, the active polyphenol of turmeric, has been evaluated as an adjunct to scaling and root planing (SRP) in multiple RCTs. A 2025 systematic review confirmed its anti-inflammatory efficacy in periodontitis, reducing gingival indices, sulcus bleeding, and inflammatory biomarkers such as CRP. It inhibits NF-κB and suppresses pro-inflammatory cytokines IL-1β, IL-6, and TNF-α relevant to periodontal pathogenesis.

DHA is an omega-3 fatty acid evaluated alongside EPA in multiple RCTs for periodontal disease. Combined EPA+DHA supplementation as adjunct to SRP has been shown in RCTs and a meta-analysis to improve probing pocket depth, clinical attachment level, and gingival inflammation in periodontitis patients. DHA generates D-series resolvins and protectins that actively promote periodontal tissue healing.

EGCG is the predominant and most bioactive catechin in green tea, directly responsible for much of its periodontal benefit. It inhibits P. gingivalis at 250–500 μg/ml, suppresses NF-κB, COX-2, and MMP-1 expression, and inhibits osteoclast-mediated alveolar bone resorption. Clinical investigations confirm its efficacy as an adjuvant therapy for periodontal disease.

Ellagic acid is a polyphenol found in pomegranate, Triphala, and other plant sources with periodontal evidence. It inhibits periodontal pathogens, reduces pro-inflammatory cytokines in gingival tissues, and is a hydrolysis product of punicalagins, the primary bioactive compounds in pomegranate with documented clinical periodontal effects.

EPA is the primary omega-3 fatty acid responsible for production of pro-resolving lipid mediators (resolvins of the E-series) that actively resolve periodontal inflammation and support tissue repair. RCTs using fish oil supplementation containing 2.6 g EPA daily as adjunct to SRP in stage III/IV periodontitis patients showed improved clinical healing and reduced periodontal bacteria counts vs. SRP alone.

Omega-3 supplementation as an adjunct to non-surgical periodontal therapy has been shown in RCTs to significantly improve clinical attachment loss and probing depth in periodontitis patients. Fish oil's anti-inflammatory EPA and DHA reduce pro-inflammatory eicosanoids driving periodontal tissue destruction. ConsumerLab notes emerging clinical evidence that post-'deep cleaning' fish oil reduces bleeding and pocketing in severe gum disease.

Fructooligosaccharides (FOS) have been evaluated as a prebiotic adjunct to probiotic therapy for periodontal disease. A clinical study by Chandra et al. (2016) reported the efficacy of Saccharomyces boulardii (1.6×10⁹ CFU) mixed 4:1 with FOS as an adjunct to non-surgical periodontal therapy, showing improvements in periodontal parameters. FOS promotes beneficial oral microbiome composition relevant to periodontal health.

Carbohydrate-derived fulvic acid (CHD-FA) has been studied as an antimicrobial oral rinse comparable to chlorhexidine for biofilm reduction. In vitro studies show fulvic acid inhibits Streptococcus mutans biofilm formation and stimulates periodontal ligament cell proliferation and collagen gene expression.

Gallic acid is a phenolic acid found in multiple plants used for periodontal disease including Triphala, pomegranate, and green tea. It demonstrates antimicrobial activity against periodontal pathogens and anticandidal properties relevant to oral biofilm control. Gallic acid is identified as the primary anticandidal component in Triphala, which has clinical evidence for gingival and periodontal conditions.

Preclinical and clinical research has identified anti-periodontitis effects of ginger through antibacterial activity against Gram-negative periodontal pathogens, suppression of pro-inflammatory cytokines, improvement of periodontal clinical parameters, and potentiation of the antioxidant defense system. A 2025 review (PMC12242689) concluded ginger may diminish inflammation and tissue damage caused by periodontitis.

Green tea catechins, especially EGCG, inhibit growth of P. gingivalis and P. intermedia, suppress COX-2 and pro-inflammatory cytokines, and reduce collagenase activity of periodontal bacteria. A 2021 systematic review (Mazur et al.) concluded that clinical periodontal parameters are positively affected by green tea. Multiple clinical studies have demonstrated its utility as an adjuvant therapy for periodontal disease.

Honey, particularly manuka, inhibits key periodontal pathogens including Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans, and clinical studies have shown reductions in plaque scores and gingival bleeding. A systematic review on apitherapy and periodontal disease (PMC9137511) summarizes in vitro, animal, and clinical trial evidence supporting honey's role in periodontal management.

Multiple randomized controlled trials support the adjunctive use of locally applied hyaluronic acid gel in non-surgical periodontal therapy. HA reduces bleeding on probing and improves clinical attachment levels when added to standard scaling and root planing. Evidence covers both generally healthy patients and those with type 2 diabetes.

Multiple randomized controlled trials demonstrate that Acacia arabica gum reduces dental plaque and gingival inflammation. A gel containing Acacia arabica showed improvements in gingival and plaque index scores comparable to 1% chlorhexidine. A separate RCT confirmed its efficacy as an adjunct to scaling and root planing in chronic periodontitis.

Early clinical research suggests knotweed root extract used as a mouth rinse may reduce bleeding and swelling of the gums in gingivitis. The root has been used in Korea to maintain oral hygiene and control oral biofilm-related diseases. Knotweed extract inhibits Streptococcus mutans and virulence factors in planktonic and biofilm cultures.

L. acidophilus inhibits the growth of key periodontal pathogens including Porphyromonas gingivalis in vitro and reduces virulence factors of Fusobacterium nucleatum. Oral administration of L. acidophilus LA5 prevented alveolar bone loss in a murine periodontitis model and reshaped dysbiotic oral and gut microbiomes. However, clinical evidence in periodontal disease is currently concentrated in in vitro and animal studies; robust human RCTs specifically for L. acidophilus in periodontitis are limited.

Lactobacillus brevis strains have been evaluated in RCTs for periodontal conditions and are among the probiotics with clinical evidence for gingivitis and periodontitis. A Frontiers in Dental Medicine review of 36 periodontal RCTs listed L. brevis among evaluated probiotic strains. L. brevis produces arginine deiminase and other enzymes that modulate the oral inflammatory environment.

L. paracasei DSMZ16671 specifically co-aggregates mutans streptococci (key caries/gum pathogens) in vitro and in human saliva, promoting their oral clearance without disrupting commensal flora. A short-term pilot RCT in humans using sugar-free candies as delivery vehicle was conducted, supported by animal data showing reduced caries scores.

Lactobacillus reuteri is the most extensively studied probiotic for periodontal disease, featured in 17 of 36 RCTs in a major review. Multiple systematic reviews confirm that adjunctive use of L. reuteri (strains DSM17938 and ATCC PTA 5289) alongside scaling and root planing improves pocket depth, clinical attachment level, and bleeding on probing in periodontitis patients. A meta-analysis of 11 RCTs (n=369) found 8/11 studies reported significant pocket depth improvement.

Lactobacillus rhamnosus strains have been evaluated in multiple RCTs for gingivitis and periodontitis management and are among the most frequently studied probiotic strains in periodontal RCTs after L. reuteri. A Frontiers in Dental Medicine review of 36 periodontal RCTs identified various L. rhamnosus strains as second most frequently evaluated probiotic strains for periodontal conditions.

Lactobacillus salivarius has been evaluated in RCTs for oral malodour, peri-implant mucositis, and gingivitis linked to periodontal conditions. L. salivarius WB21-containing tablets were evaluated in a double-blind RCT for oral malodour, and strain studies demonstrate suppression of IL-6 and IL-8 from gingival fibroblasts when challenged with periodontal pathogens. Multiple probiotic periodontal trials have included L. salivarius strains.

Lactoferrin is a natural component of saliva and has documented antibacterial activity against key periodontopathic bacteria including Porphyromonas gingivalis. Clinical studies support its role in reducing periodontal bacterial load and inflammation. Research reviews confirm its protective role in gingivitis and periodontitis.

LPO-containing oral products have been studied in gingivitis and chronic periodontitis patients. A 2025 systematic review found enzyme/protein toothpastes including LPO useful for preventing gingivitis and managing gingival inflammation. An RCT (Nakano et al. 2019) found tablets with LPO and lactoferrin improved gingival health in adults. However, a 72-person RCT in chronic periodontitis found only weak effects on clinical and bacteriological parameters after 12 weeks of oral tablet use.

Lemon is a primary dietary source of vitamin C, which plays an essential role in collagen synthesis for periodontal ligament integrity and gum tissue health. Deficiency causes scurvy with characteristic gum bleeding; correcting deficiency with vitamin C (from sources such as lemon) reverses periodontal symptoms. Clinical studies link lower serum vitamin C to more severe periodontal disease.

Multiple RCTs demonstrate that 0.25% lemongrass oil mouthwash reduces plaque and gingivitis with similar efficacy to 0.2% chlorhexidine. A 2% lemongrass oil gel applied as local drug delivery during scaling and root planing showed comparable benefits to doxycycline for chronic periodontitis. A 2024 scoping review confirmed these as the strongest area of clinical evidence for LGEO.

Licorice root (Glycyrrhiza glabra) and its active compound glycyrrhizin/glabridin have demonstrated antimicrobial and anti-inflammatory properties relevant to periodontal disease. A PMC review confirmed licorice as one of the two primary herbal ingredients reviewed for anti-periodontal properties in toothpastes and mouthwashes. A licorice-Triphala gum paint formulation showed clinical efficacy for periodontal disease.

Several RCTs and a systematic review with meta-analysis have evaluated lycopene as an adjunct to scaling and root planing (SRP) in periodontitis patients. Lycopene (4–8 mg/day) adjunct therapy showed significant improvement in clinical attachment level (CAL) and other periodontal parameters. A 2024 Cochrane-method meta-analysis assessed six periodontal parameters across multiple RCTs.

Magnolia bark extract demonstrates antibacterial activity against Porphyromonas gingivalis, the primary pathogen in periodontal disease. Clinical trials using MBE-containing chewing gum showed reduced gingival bleeding on probing. A randomized trial with MBE-containing toothpaste showed reduced plaque and improved gum disease markers in 48 participants over 6 months.

Adhatoda vasica is an ingredient in multi-herb Ayurvedic toothpastes tested in clinical trials for plaque and gingivitis. A double-blind RCT (n=60) of a nine-herb toothpaste including A. vasica tested gingival bleeding and plaque, and WebMD cites a 2015 double-blind RCT in chronic gingivitis patients.

Multiple small clinical studies have shown mangosteen pericarp preparations improve periodontal parameters. A 4% mangostana gel applied into periodontal pockets showed significant improvement in chronic periodontitis. A herbal mouthwash with pericarp extract reduced volatile sulfur compounds (halitosis-related) and improved plaque and bleeding indices in a 60-person gingivitis study.

A 2023 systematic review of 14 studies (LSHTM/Journal of Natural Medicines) confirmed mastic gum inhibits periodontal pathogens including P. gingivalis, A. actinomycetemcomitans, and F. nucleatum, outperforming 3% hydrogen peroxide. Clinical trials show significant reductions in gingival index and plaque index with mastic formulations. The EMA recognizes mastic for mild inflammatory oral conditions.

Multiple RCTs support the use of 5% TTO gel, applied subgingivally as an adjunct to scaling and root planing (SRP), for improving clinical periodontal outcomes including pocket depth, attachment level, and inflammatory biomarkers. A 2023 systematic review of 18 dental RCTs found that 5% TTO gels aid treatment of periodontitis as adjunctive therapy, and 0.2–0.5% TTO mouthwashes may limit dental plaque accumulation.

Melatonin applied topically or systemically as an adjunct to non-surgical periodontal therapy has been shown to reduce periodontal pocket depth in multiple RCTs. A 2021 meta-analysis of two RCTs found that combined non-surgical periodontal therapy plus melatonin significantly reduced pocket depths vs. treatment alone. Its antioxidant and anti-inflammatory properties modulate oxidative stress in periodontal tissues.

Menthol is an active ingredient in essential oil mouthwashes that have received the ADA Seal of Acceptance for reducing plaque and gingivitis. Clinical evidence supports its role in disrupting bacterial biofilms and inhibiting oral pathogens associated with periodontal disease.

Peppermint oil has demonstrated antibacterial activity against periodontal pathogens including Fusobacterium nucleatum in vitro. Mouthwashes containing mint essential oils show reductions in plaque index, bleeding on probing, and gingival index in clinical studies. Menthol-containing mouthwashes (e.g., Listerine) have extensive clinical evidence for periodontal benefit.

A human in vivo study found that a mouthwash containing lysine and GML reduced oral H. pylori infection at a 72.58% effectiveness rate — far superior to traditional dental cleaning (under 10%). In vitro studies further show GML-containing mouthwash inhibits H. pylori growth, biofilm, adhesion, and virulence factor expression in periodontal context.

Mustard seed extract and mustard oil have demonstrated clinically meaningful antimicrobial and anti-inflammatory activity relevant to periodontal disease. A double-blind dental RCT with white mustard toothpaste (n=113) reduced plaque index and bleeding on probing. Multiple in vitro and pilot clinical studies support use as an adjunct to nonsurgical periodontal therapy.

Myristoleic acid has been shown in vitro to be the only one of 45 fatty acids surveyed capable of inhibiting Selenomonas artemidis — a bacterium found in high amounts in patients with periodontal disease — at concentrations below 100 µg/mL. This is in vitro evidence only, from the free acid form of the ingredient.

A double-blind RCT in 78 patients found TC 10% mouthwash to be as effective as chlorhexidine 0.12% in reducing dental plaque, gingival inflammation, and normalizing salivary pH over 2 weeks. Laboratory studies confirm TC inhibits key periodontal pathogens and suppresses DPB-induced bone resorption.

Neem (Azadirachta indica) mouthwash and extract have been evaluated in clinical studies for plaque-induced gingivitis and periodontal infection, with studies finding neem extract mouth rinse to be similarly effective as chlorhexidine in reducing periodontal infection symptoms. Neem twigs have been used traditionally as chewing sticks for gum health across South and Southeast Asia for centuries. A clinical study in 50 gingivitis patients showed 80% improvement after 3 weeks of neem paste.

Multiple RCTs and meta-analyses support omega-3 fatty acid supplementation as an adjunct to scaling and root planing for periodontitis, with benefits including reduced bleeding on probing, reduced pocket depth, improved clinical attachment level, and decreased periodontal pathogen counts. A 2020 RCT in 90 periodontitis patients found 1 g EPA+DHA/day for 1 month significantly improved multiple periodontal parameters vs. SRP alone.

Oregano essential oil demonstrates potent in vitro antimicrobial activity against major periodontal pathogens including S. mutans, S. aureus, Enterococcus faecalis, and Candida albicans, achieving >99.99% killing in IADR-reported studies. OEO was found equivalent in antimicrobial potency to Listerine Naturals™ against organisms associated with periodontal disease. Anti-biofilm activity against dental plaque has been confirmed in both in vitro and animal models.

An open randomized clinical trial of 84 patients with moderate-to-severe chronic periodontitis found that standardized fermented papaya gel (SFPG), applied intragingival for 10 days as an adjunct to standard care, produced significant improvements in bleeding, plaque, gingival index, and pocket depth reduction compared to controls. Pro-inflammatory cytokines (IL-1β, IL-6) normalized in the SFPG group but not in controls.

Peppermint oil has documented antimicrobial effects against key periodontal pathogens including Prevotella and Porphyromonas species. Its menthol, menthone, and flavonoid constituents provide antibacterial, anti-inflammatory, and analgesic properties relevant to gingival conditions. Clinical literature and Frontiers in Antibiotics (2026) document peppermint as providing relief for periodontal disease and dental pain through these mechanisms.

A clinical study (Kimbrough et al., Phytomedicine 2002) found that Pycnogenol chewing gum significantly minimized gingival bleeding and plaque formation. The American Botanical Council monograph lists oral/gum health as a studied indication. A systematic review of 39 RDP trials confirmed oral health as a demonstrated benefit.

A 2025 RCT (n=91) demonstrated Pycnogenol 100 mg twice daily significantly reduced salivary MMP-8 and serum IL-6 vs. placebo during non-surgical periodontal therapy. Animal studies show inhibition of alveolar bone resorption in periodontitis models. Evidence supports Pycnogenol as an adjunct to mechanical plaque removal.

Bromelain has been evaluated in clinical trials for periodontal surgery, showing significant pain reduction after gingival grafting and anti-inflammatory benefits. It also inhibits growth of periodontitis-associated microorganisms and reduces neutrophil chemotaxis in the periodontal region.

Pomegranate fruit extract (Punica granatum) has been evaluated in clinical studies as an adjunct to SRP for adult periodontitis using pomegranate chips and gels. A review of plant materials in periodontitis management listed pomegranate among those with demonstrated advantages for periodontitis relief. Pomegranate mouthwashes have been shown to reduce gingival bleeding index.

Quercetin has been identified as one of the natural products with the highest antioxidant, anti-inflammatory, and antimicrobial activity for periodontal disease in a comprehensive review. It improves oxidative stress of periodontal ligament cells, prevents alveolar bone resorption, and dampens production of IL-1β, IL-6, IL-8, and TNF-α. Preclinical evidence supports its role against crestal bone loss in periodontitis.

A published in vitro study (PMID 9276981) specifically demonstrated that Ceanothus americanus extracts inhibit key periodontal pathogens including Porphyromonas gingivalis and Prevotella intermedia. This constitutes direct laboratory evidence for a gum health mechanism. Traditional use as an oral rinse also supports this application. Human clinical trials have not been conducted.

Resveratrol has been shown in clinical RCTs to slow periodontal disease progression and reduce probing pocket depth when used as an adjunct to SRP. A 2021 meta-analysis found resveratrol supplementation with SRP significantly improved probing pocket depth vs. SRP alone. Preclinical research confirms it reduces crestal bone loss and downregulates key inflammatory mediators in periodontal tissues.

Serratiopeptidase has been studied and applied in dentistry for periodontitis, pericoronitis, and post-extraction inflammation. It is used as an anti-inflammatory agent to increase antibiotic tissue penetration at periodontal infection sites. A 2014 study examined ciprofloxacin-serratiopeptidase periodontal solutions for extended drug delivery at gum sites. Multiple dental RCTs document anti-inflammatory benefits post-extraction.

Sesame oil oil-pulling has been evaluated in clinical trials for plaque reduction and gingivitis. A 2025 RCT (40 volunteers, Medical University of Innsbruck) found significantly higher plaque reduction with sesame oil than distilled water. An earlier study in boys with gingivitis showed that sesame oil pulling reduced plaque, improved gingivitis, and reduced harmful oral bacteria comparably to standard mouthwash.

Shiitake mushroom extracts show significant antibacterial activity against key periodontal pathogens including Porphyromonas gingivalis, Fusobacterium nucleatum, and Aggregatibacter actinomycetemcomitans in vitro. Unlike chlorhexidine, shiitake extract reduces harmful bacteria while preserving beneficial oral microbiota. Evidence is currently limited to in vitro and laboratory models.

SPMs were originally identified in resolving inflammatory exudates in periodontal tissue. Reduced SPM levels in saliva and gingival fluid are associated with aggressive periodontal disease. A stable SPM analog was in clinical trial for periodontal inflammation. Human periodontal stem cells produce SPMs including resolvin D6.

Norway spruce (Picea abies) resin extract has been evaluated in rigorous in vitro studies for anti-inflammatory and anti-plaque effects relevant to periodontal health. A 20% concentration suppressed pro-inflammatory cytokines (IL-1β, TNF-α, MMP-3) comparably to a corticosteroid. A toothpaste formulation with 20% spruce resin extract was tested against oral pathogens with significant antimicrobial results and demonstrated biocompatibility in human gingival 3D models.

In vitro studies show stevia extracts inhibit key periodontal pathogens including Porphyromonas gingivalis and reduce biofilm formation. Animal studies demonstrated stevia reduced alveolar bone resorption and periodontal inflammation. A small clinical study found stevia gel in the gingival crevice of diabetic patients with periodontitis improved clinical periodontal parameters.

Strawberries provide high levels of vitamin C, an obligate cofactor for gum collagen synthesis; deficiency in vitamin C manifests as hemorrhagic gingivitis. Higher dietary vitamin C intake is associated with lower periodontal disease risk epidemiologically. Strawberry polyphenols additionally demonstrate in vitro antimicrobial and anti-inflammatory activity relevant to gum tissue.

Streptococcus salivarius K12 and M18 strains inhibit immune activation induced by periodontal pathogens P. gingivalis, A. actinomycetemcomitans, and F. nucleatum in human gingival fibroblasts, significantly reducing IL-6 and IL-8 release. S. salivarius produces salivaricins (bacteriocins) with antimicrobial activity against oral pathogens. A novel SALI-10 strain is currently in clinical trials for experimental gingivitis.

Oil pulling with sunflower oil has been clinically shown to significantly reduce plaque index and gingival index scores. A study using refined sunflower oil (45 days) showed 18–30% reduction in plaque scores and 52–60% reduction in gingivitis. Multiple published studies document this effect, and review evidence supports sunflower oil oil-pulling as an adjunct for plaque-induced gingivitis.

Tea tree oil (Melaleuca alternifolia) contains terpinen-4-ol and has been evaluated clinically and in systematic reviews for gingivitis and periodontal disease. A commercial tea tree therapy mouthwash is marketed specifically for periodontal conditions. Clinical studies have demonstrated antimicrobial activity against periodontal pathogens and reductions in gingival inflammation.

T. chebula has demonstrated antimicrobial activity against key oral pathogens including Streptococcus mutans, Porphyromonas gingivalis, and Aggregatibacter actinomycetemcomitans in vitro and in a randomized crossover trial. Its decoction is traditionally used as a gargle for gum bleeding and oral ulcers. Triphala mouthwash (containing T. chebula) has been tested in clinical periodontal trials.

Thymol, derived from thyme, is the principal active agent in essential oil mouthwashes such as Listerine and is supported by multiple randomized clinical trials and systematic reviews demonstrating reductions in dental plaque and gingivitis. A dedicated thyme mouthwash RCT found significant improvement in gingival index and halitosis versus controls. The American Dental Association recognizes essential oil mouthwashes containing thymol as effective adjuncts.

Thymol from Thymus vulgaris is an established active ingredient in antiseptic mouthwashes (e.g., Listerine) and has strong in vitro antibacterial activity against major oral pathogens implicated in periodontal disease, including Streptococcus mutans and other gum pathogens. The ESCOP monograph documents thyme's traditional use as a mouthwash for gum inflammation. In vitro evidence is robust; dedicated periodontal clinical trials are limited.

Triphala (a combination of Emblica officinalis, Terminalia chebula, and Terminalia bellirica) has been evaluated in clinical studies as a mouthwash for plaque and gingivitis, showing antimicrobial efficacy comparable to chlorhexidine in some trials. It contains gallic acid, punicalagins, chebulagic acid, and tannins with proven antimicrobial and antioxidant activity. A novel licorice-Triphala gum paint formulation showed clinical efficacy for periodontal disease.

Clinical and pre-clinical evidence supports curcumin's efficacy in periodontal disease management through anti-inflammatory and antibacterial mechanisms against periodontopathogens. A 2025 PMC systematic review confirmed curcumin's positive effects on gingival inflammation. Curcumin is also used as an adjunctive local delivery agent in scaling and root planing.

CoQ10 deficiency has been documented in gingival tissue of periodontitis patients since the 1970s. A 2025 systematic review of RCTs (PubMed PMID 39920883) found that oral CoQ10 supplementation (120 mg/day) used adjunctively with scaling and root planing produced significantly greater reductions in probing depth and clinical attachment level gains versus scaling alone after 12 weeks.

Observational studies consistently link higher serum folate to reduced periodontal disease risk. A systematic review found each standard deviation increase in serum folate was associated with approximately 26% lower odds of periodontal disease. Folate deficiency impairs gingival keratinization, collagen formation, and resistance to infection. Folate mouthwash and dietary folate have both been associated with reduced gingival bleeding.

Vitamin C (ascorbic acid) plays a critical role in collagen synthesis and periodontal connective tissue integrity. Multiple epidemiological studies and a systematic review confirm that low vitamin C intake/status is associated with increased periodontal disease risk and severity. A 2024 systematic review and meta-analysis found vitamin C supplementation provides a protective effect on periodontal health by neutralizing reactive oxygen species and supporting connective tissue repair.

Vitamin D has been examined in multiple RCTs and systematic reviews for its role in periodontal health. A 2023 systematic review concluded vitamin D may serve as a beneficial adjunct to periodontal therapy, particularly in deficient individuals. Its mechanisms include modulation of bone metabolism (critical to alveolar bone), anti-inflammatory effects, and enhancement of innate immune defense against periodontal pathogens.

Vitamin D3 (cholecalciferol) is the more bioavailable form of vitamin D evaluated in RCTs for periodontal disease as an adjunct to periodontal therapy. Clinical trials evaluating specific vitamin D doses (500–2000 IU/day) have predominantly used cholecalciferol. Its bone-protective, anti-inflammatory, and immunomodulatory properties are directly relevant to alveolar bone preservation and periodontal inflammation control.

Vitamin E (tocopherol) has been reviewed in the context of periodontal health as an antioxidant vitamin. A systematic review on vitamins in periodontal health (PMC6099579) found that vitamins with antioxidant capacity and immune-modulating effects—including vitamin E—show evidence of benefit for periodontal disease prevention or improvement. Clinical and nutritional reviews of periodontal disease include vitamin E among key nutritional elements.

6-MSITC from wasabi inhibited production of IL-6 and CXCL10 in TNF-α-stimulated human oral epithelial cells, suppressing inflammatory signaling pathways (STAT3, NF-κB, p70S6K). Additionally, wasabi isothiocyanates have demonstrated antimicrobial activity relevant to oral pathogens and dental plaque bacteria. In Japan, wasabi has a documented traditional role as an antimicrobial food preservative.

Methyl salicylate is an established antimicrobial ingredient in ADA-recognized antiplaque and antigingivitis mouthrinses. In vitro studies confirm wintergreen essential oil exhibits antimicrobial activity against oral pathogens. G. procumbens extracts are traditionally used for skin and periodontal problems, with in vitro support for anti-inflammatory action relevant to gingivitis.

Laboratory and animal evidence supports Zanthoxylum's antimicrobial and anti-inflammatory effects relevant to periodontal health. Z. zanthoxyloides is used as a chewing stick in West Africa, showing activity against periodontal pathogens. A 2025 animal study of Zanthoxyli Pericarpium (ZP) extract demonstrated protection against ligature-induced periodontitis in rats via combined antimicrobial, anti-inflammatory, and anti-resorptive mechanisms.

Zinc is an antimicrobial and anti-inflammatory mineral used as zinc chloride and zinc oxide in toothpastes and mouthwashes with documented efficacy for reducing periodontal plaque and gingivitis. A systematic review of active ingredients for periodontal diseases (PMC8037529) includes zinc compounds among the major oral care active ingredients reviewed for antiplaque and anti-gingivitis properties.

Agrimony is traditionally used as a mouthwash or gargle for inflammation of the oral mucosa, including the gums. This use is recognised in official monographs by the German Commission E and ESCOP. The astringent action of tannins is considered to underlie the benefit to gingival tissue.

Baltic amber necklaces have been used traditionally for teething pain relief in infants, which includes gum inflammation and swelling. Historical records document amber in ancient remedies for throat, ear, and oral complaints. Clinical evidence for amber-specific effects on gum health is absent.

Bayberry has a documented traditional use as a mouthwash and toothpowder for sore, bleeding, and sensitive gums. Its astringent tannins are proposed to reduce gum bleeding and inflammation by tightening mucosal tissue. TCM has used bayberry for mouth and gum problems for over 2,000 years. No clinical trials have been conducted.

Traditional Ayurvedic texts describe the use of belleric myrobalan fruit powder as a tooth powder for gum pain. The antimicrobial activity of its polyphenols against oral pathogens provides mechanistic support. Triphala (containing T. bellirica) is documented as a traditional mouthwash and gargle. No human RCT specifically for periodontal health using T. bellirica monotherapy has been published.

The British Herbal Pharmacopoeia lists black spruce for gingivitis, constituting a formal pharmacopoeia-level traditional use. Indigenous peoples in Europe also reportedly used black spruce for gum and oral conditions. No clinical periodontal trials have been published.

Camu camu has traditional use among Amazonian native tribes specifically for periodontal and gum health. Scientifically, vitamin C deficiency causes scurvy-related gum bleeding and periodontal breakdown; vitamin C sufficiency supports gingival collagen integrity and immune defense. No dedicated camu camu periodontal RCT has been published.

Clove (Syzygium aromaticum) and its primary constituent eugenol have centuries of use in traditional dentistry for gum pain, inflammation, and oral infections. Eugenol is a recognized antiseptic and analgesic used in professional dental preparations. Clove is included in multiple commercial herbal dental products specifically for gingivitis and periodontal conditions.

Eucalyptus essential oil and its constituent 1,8-cineole have been used traditionally and are incorporated into commercial herbal dental products for gingivitis and periodontal conditions. Eucalyptus is included as an active ingredient in herbal toothpastes (e.g., Colgate Anticavity Herbal) and mouthwashes for periodontal disease. It demonstrates antimicrobial activity against periodontal pathogens.

Goldenseal is traditionally used as a mouthwash and gum treatment for gingivitis and periodontal inflammation, based on its antimicrobial and astringent effects on oral mucosa. No rigorous periodontal clinical trials of goldenseal per se have been identified.

Traditional Indigenous and herbal use of huckleberry leaf and bark decoctions included gargling for inflamed gums, documented in Pacific Northwest ethnobotanical records. Bilberry anthocyanins have also been associated with periodontal health in modern herbal references, attributed to anti-inflammatory and capillary-strengthening properties relevant to gingival tissue.

Traditional and ethnobotanical records document use of Lophatherum leaf for swollen gums, glossitis, and periodontitis. The GlobinMed database records treatment of buccal sores and swollen gums. A 2025 study references its use for glossitis and periodontitis. In vitro antibacterial activity against oral pathogens (Staphylococcus aureus, Streptococcus haemolyticus) provides partial mechanistic support.

Myrrh (Commiphora myrrha) has centuries of use in traditional medicine for gum inflammation, bleeding gums, and oral infections. It is included as an active ingredient in herbal dental products for periodontal conditions by major commercial brands and is listed in herbal dentistry reviews for gum disease management. Commiphora resin constituents have demonstrated antimicrobial and anti-inflammatory activity relevant to periodontal tissues.

Plantago major and P. lanceolata are documented for anti-inflammatory and antimicrobial activity relevant to periodontal health. Commission E and ESCOP list inflammation of the oral mucosa as an indication. P. major extract is being investigated for antibiofilm activity against Streptococcus mutans and periodontal pathogens.

Prickly ash has documented traditional use for gum health — including gum disease, periodontitis, gingivitis, and canker sores — consistent with its antimicrobial, local anesthetic, and anti-inflammatory properties. Native American tribes applied crushed bark to the gums, and herbalist dental texts support this use. No clinical trials in periodontal disease have been conducted.

Raspberry leaf infusion has a documented traditional use as a mouthwash for inflamed and spongy gums (gingivitis), bleeding gums, and oral inflammations. The astringent tannins are credited with toning and tightening gingival tissue. Multiple herbal monographs and practitioners record its use as a topical wash for bleeding gums and periodontal inflammation. No clinical periodontal trials have been conducted.

Sage (Salvia officinalis) has long-established traditional use in European herbal medicine for stomatitis, gingivitis, sore throat, and periodontal infections. As a mouthwash, sage deals efficiently with various throat infections, mouth ulcers, and gum diseases like gingivitis. It is included in herbal dental products and endorsed by authoritative traditional medicine sources for oral mucosal inflammation.

Solomon's seal has been used as a mouthwash and gargle to strengthen gums and fasten loose teeth since at least the 16th century. Culpeper and other herbalists document this application; the astringent and antimicrobial properties of the rhizome underpin the traditional use.

White oak bark has documented traditional use as a mouthwash and topical agent for bleeding gums, gingivitis, and periodontal inflammation. Oak bark tannins exhibit bactericidal activity against oral pathogens in vitro. A PMC review on plant materials for periodontal disease specifically identifies oak bark among candidates with astringent, bactericidal, and anti-inflammatory properties.